Технико-технологическое обоснование оснащения газовых скважин концентрическими лифтовыми колоннами на Ямбургском нефтегазоконденсатном месторождении (ЯНАО)

Проанализированы методики расчета режимов работы скважин, оборудованных концентрическими лифтовыми колоннами с учетом объема пластовой и конденсационной жидкости, содержащейся в их продукции.Methods for calculating the operating modes of wells equipped with concentric lift columns are analyzed, taking into account the volume of reservoir and condensation fluid contained in their products

Impact of pulsed direct current on embryos, larvae, and young juveniles of Atlantic cod and its implications for electrotrawling of brown shrimp

The application of electrical pulses in fishing gear is considered a promising option to increase the sustainability of demersal trawl fisheries. In the electrotrawl fishery for brown shrimp Crangon crangon, an electrical field selectively induces a startle response in the shrimp. Other benthic organisms remain mainly on the seafloor and escape underneath a hovering trawl. Previous experiments have indicated that this pulse has no short-term major harmful effects on adult fish and invertebrates. However, the impact on young marine life stages is still unknown. Because brown shrimp are caught in shallow coastal zones and estuaries, which serve as important nurseries or spawning areas for a wide range of marine species, electrotrawling on these grounds could harm embryos, larvae, and juveniles. We carried out experiments with different developmental stages of Atlantic Cod Gadus morhua, which are considered vulnerable to electrical pulses. Three embryonic stages, four larval stages, and one juvenile stage of Atlantic Cod were exposed to a homogeneous electrical field of 150 V-peak/m for 5 s, mimicking a worst-case scenario. We detected no significant differences in embryo mortality rate between control and exposed groups. However, for the embryonic stage exposed at 18 d postfertilization, the initial hatching rate was lower. Larvae that were exposed at 2 and 26 d posthatch exhibited higher mortality rates than the corresponding nonexposed control groups. In the other larval and juvenile stages, no short-term impact of exposure on survival was observed. Morphometric analysis of larvae and juveniles revealed no differences in measurements or deformations of the yolk, notochord, eye, or head. Although exposure to a worst-case electrical field did not impact survival or development for six of the eight young life stages of Atlantic Cod, the observed delayed hatching rate and decreased survival for larvae might indicate an impact of electric pulses and warrant further research

Status of the BELLE II Pixel Detector

The Belle II experiment at the super KEK B-factory (SuperKEKB) in Tsukuba, Japan, has been collecting $e^+e^−$ collision data since March 2019. Operating at a record-breaking luminosity of up to $4.7×10^{34} cm^{−2}s^{−1}$, data corresponding to $424 fb^{−1}$ has since been recorded. The Belle II VerteX Detector (VXD) is central to the Belle II detector and its physics program and plays a crucial role in reconstructing precise primary and decay vertices. It consists of the outer 4-layer Silicon Vertex Detector (SVD) using double sided silicon strips and the inner two-layer PiXel Detector (PXD) based on the Depleted P-channel Field Effect Transistor (DePFET) technology. The PXD DePFET structure combines signal generation and amplification within pixels with a minimum pitch of $(50×55) μm^2$. A high gain and a high signal-to-noise ratio allow thinning the pixels to $75 μm$ while retaining a high pixel hit efficiency of about $99$. As a consequence, also the material budget of the full detector is kept low at $≈0.21$$\frac{X}{X_0}$ per layer in the acceptance region. This also includes contributions from the control, Analog-to-Digital Converter (ADC), and data processing Application Specific Integrated Circuits (ASICs) as well as from cooling and support structures. This article will present the experience gained from four years of operating PXD; the first full scale detector employing the DePFET technology in High Energy Physics. Overall, the PXD has met the expectations. Operating in the intense SuperKEKB environment poses many challenges that will also be discussed. The current PXD system remains incomplete with only 20 out of 40 modules having been installed. A full replacement has been constructed and is currently in its final testing stage before it will be installed into Belle II during the ongoing long shutdown that will last throughout 2023

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

Geld und Gesellschaft in der "Philosophie des Geldes"

Rammstedt O. Geld und Gesellschaft in der "Philosophie des Geldes". In: Binswanger HC, von Flotow P, eds. Geld & Wachstum : zur Philosophie und Praxis des Geldes. 1st ed. Stuttgart: Weitbrecht; 1994: 15-32